Michael Eisenhut

The diagnostic value of PET/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer

Ali Afshar‐Oromieh, Eleni Avtzi, Frederik L. Giesel et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2014 · 974 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Comparison of PET imaging with a 68Ga-labelled PSMA ligand and 18F-choline-based PET/CT for the diagnosis of recurrent prostate cancer

Ali Afshar‐Oromieh, Christian M. Zechmann, A. Malcher et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2013 · 928 citations · Full text

Medicine, Nuclear Medicine, Radiology +17

Comparison of 68Ga-DOTATOC PET and 111In-DTPAOC (Octreoscan) SPECT in patients with neuroendocrine tumours

Inga Buchmann, Marcus Henze, Swantje Engelbrecht et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2007 · 507 citations

Medicine, Nuclear Medicine, Oncology +14

[68Ga]Gallium-labelled PSMA ligand as superior PET tracer for the diagnosis of prostate cancer: comparison with 18F-FECH

Ali Afshar‐Oromieh, Uwe Haberkorn, Matthias Eder et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2012 · 332 citations

Medicine, Nuclear Medicine, Oncology +14

Radiation dosimetry of 68Ga-PSMA-11 (HBED-CC) and preliminary evaluation of optimal imaging timing

Ali Afshar‐Oromieh, Henrik Hetzheim, W Kübler et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2016 · 186 citations

Medicine, Radiation Oncology, Radiology +14